Biogen IDEC Inc Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (65)

Latest Posts

About This Stock More About This Stock
Goldman Sachs: 4 Killer Stock Picks For 2019 (Part II)
Article By: TipRanks
Thursday, December 6, 2018 10:15 AM EST
Goldman Sachs has just released a report that highlights exactly the kind of stocks you want to be thinking about right now.
In this article: V, BIIB, DLTR, BKNG
Read
Week In Review: Alphamab Closes $100 Million Series A For Oncology Candidates
Article By: ChinaBio® Today
Saturday, November 24, 2018 4:09 PM EST
Alphamab Oncology, a clinical-stage Suzhou biopharma, completed a Series A funding with over $100 million in capital. Earlier this year, Alphamab Oncology was spun out of Suzhou Alphamab with seven oncology assets and related technology platforms.
In this article: LLY, CASI, BIIB, GILD
Read
3 Drug/Biotech Stocks In Focus On World Alzheimer's Day
Article By: Zacks Investment Research
Friday, September 21, 2018 2:57 PM EST
Here we take a look at companies with promising candidates in their pipeline for Alzheimer’s Disease (AD).
In this article: RHHBY, BIIB Also: AGN
Read
Biotech ETFs In Focus On String Of Q2 Earnings Beats
Article By: Zacks Investment Research
Sunday, August 12, 2018 4:27 PM EST
The biotech sector has been performing remarkably well driven by a wave of mergers and acquisitions, new tax legislation, and a positive regulatory backdrop. Strong Q2 earnings results have added to the strength as biotech giants topped estimates.
In this article: IBB, AMGN, GILD, BBH, FBT, ALXN, BIIB
Read
5 Cheap PEG Stocks Suitable For GARP Investors
Article By: Zacks Investment Research
Thursday, August 2, 2018 1:12 PM EST
Investors seeking long-term growth often wonder whether they should resort to any of the fundamental strategies like growth or value. Going by Warren Buffett, these two approaches are joined at the hip.
In this article: HCA, TMO, BIIB, GILD, QCOM
Read

PARTNER HEADLINES

Latest Tweets for $BIIB

No tweets yet!

$BIIB

Alert: Alzheimer’s Drug Fails In Clinical Trial - Stocks Sink
Craig Newman 11/24/2016 5:28:00 AM

What are the chances of $BIIB and $TSRO being bought out? They have long been targets, or at least rumored to be, for consolidation.

1 to 1 of 1 comments